- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tectonic Therapeutic Inc (TECX)
Track the Tectonic Therapeutic share price today and view real-time TECX share price data, including charts, technicals, and key financials. View the TECX premarket stock price ahead of the market session or assess the after hours quote. Explore TECX stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Tectonic Therapeutic Stock Price Today?
The Tectonic Therapeutic stock price today is 22.350.
What Is the Stock Symbol for Tectonic Therapeutic?
The stock symbol for Tectonic Therapeutic is ""TECX.""
What Stock Exchange Does Tectonic Therapeutic Trade On?
Tectonic Therapeutic is listed and trades on the NASDAQ stock exchange.
Is Tectonic Therapeutic a Good Stock to Buy?
Determining whether Tectonic Therapeutic or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TECX quote. (ISIN: US8789721086)
What Is the Tectonic Therapeutic Stock Price Today?
The Tectonic Therapeutic stock price today is 22.350.
What Is the Stock Symbol for Tectonic Therapeutic?
The stock symbol for Tectonic Therapeutic is ""TECX.""
What Stock Exchange Does Tectonic Therapeutic Trade On?
Tectonic Therapeutic is listed and trades on the NASDAQ stock exchange.
Is Tectonic Therapeutic a Good Stock to Buy?
Determining whether Tectonic Therapeutic or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TECX quote. (ISIN: US8789721086)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.260
23.115
52 wk Range
15.450
39.528
TECX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22.26023.115
52 wk Range
15.45039.528
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TECX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
76.625
Upside
+242.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
AVROBIO receives Investment Bank Analyst Rating Update- Investing.com
Pro
Form 144 TECTONIC THERAPEUTIC For: 1 October- Investing.com
- AVROBIO receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 144 TECTONIC THERAPEUTIC For: 1 October
- Investing.com
AVROBIO receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 76.625
(+242.84% Upside)
Earnings
Latest Release
06/08/2026
EPS / Forecast
-1.18 / -1.35
Revenue / Forecast
-- / --
Compare TECX to Peers and Sector
Metrics to compare | TECX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTECXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.1x | −5.9x | −0.3x | |
PEG Ratio | 0.38 | 0.26 | 0.00 | |
Price/Book | 2.0x | 2.1x | 2.6x | |
Price / LTM Sales | - | 26.5x | 3.0x | |
Upside (Analyst Target) | 218.7% | 91.0% | 62.1% | |
Fair Value Upside | Unlock | −1.4% | 8.1% | Unlock |
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tectonic Therapeutic (TECX) Stock Price Today?
The Tectonic Therapeutic stock price today is 22.350 USD.
What Stock Exchange Does Tectonic Therapeutic Trade On?
Tectonic Therapeutic is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tectonic Therapeutic?
The stock symbol for Tectonic Therapeutic is "TECX."
What Is the Tectonic Therapeutic Market Cap?
As of today, Tectonic Therapeutic market cap is 436.930M USD.
What Is Tectonic Therapeutic's Earnings Per Share (TTM)?
The Tectonic Therapeutic EPS (TTM) is -4.565.
When Is the Next Tectonic Therapeutic Earnings Date?
Tectonic Therapeutic will release its next earnings report on 05/11/2026.
From a Technical Analysis Perspective, Is TECX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tectonic Therapeutic Stock Split?
Tectonic Therapeutic has split 1 times.
How Many Employees Does Tectonic Therapeutic Have?
Tectonic Therapeutic has 60 employees.
What is the current trading status of Tectonic Therapeutic (TECX)?
As of 13/10/2026, Tectonic Therapeutic (TECX) is trading at a price of 22.350 USD, with a previous close of 22.350 USD. The stock has fluctuated within a day range of 22.260 USD to 23.115 USD, while its 52-week range spans from 15.450 USD to 39.528 USD.
What Is Tectonic Therapeutic (TECX) Price Target According to Analysts?
The average 12-month price target for Tectonic Therapeutic is 76.625 USD, with a high estimate of 93 USD and a low estimate of 60 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +242.84% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.